Illumina Inc. (ILMN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 481 |
| % of all portfolios: | 0.081% |
| Hold Price * : | $123.26 |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q1  2026 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 5.38% | 30,988 | 0.14 | |
| ≡ | Triple Frond Partners | Reduce 18.09% | 67,700 | 0.87 | |
| Q4  2025 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 0.96% | 5,591 | 0.03 | |
| ≡ | Triple Frond Partners | Reduce 4.21% | 16,440 | 0.22 | |
| Q3  2025 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 0.14% | 831 | 0.00 | |
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 9,351 | 0.01 | |
| ≡ | AKO Capital | Sell 100.00% | 533,954 | 0.64 | |
| ≡ | Triple Frond Partners | Buy | 390,600 | 4.04 | |
| Q2  2025 | |||||
| ≡ | Carl Icahn - Icahn Capital Management | Sell 100.00% | 220,000 | 0.23 | |
| ≡ | AKO Capital | Reduce 39.99% | 355,760 | 0.43 | |
| ≡ | Samantha McLemore - Patient Capital Management | Add 26.93% | 123,521 | 0.53 | |
| Q1  2025 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 212.32% | 6,357 | 0.01 | |
| ≡ | Carl Icahn - Icahn Capital Management | Add 450.00% | 180,000 | 0.19 | |
| ≡ | Samantha McLemore - Patient Capital Management | Add 11.88% | 48,714 | 0.20 | |
| ≡ | AKO Capital | Add 79.64% | 394,428 | 0.41 | |
| Q4  2024 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 0.39% | 1,600 | 0.01 | |
| ≡ | Lee Ainslie - Maverick Capital | Reduce 81.41% | 13,115 | 0.04 | |
| ≡ | Carl Icahn - Icahn Capital Management | Reduce 90.70% | 390,000 | 0.68 | |
| ≡ | AKO Capital | Buy | 495,286 | 0.91 | |
| Q3  2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 7.09% | 1,229 | 0.00 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 0.80% | 3,303 | 0.02 | |
| Q2  2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 615.26% | 14,914 | 0.03 | |
| ≡ | ValueAct Capital | Sell 100.00% | 243,777 | 0.74 | |
| ≡ | Samantha McLemore - Patient Capital Management | Add 69.13% | 169,571 | 0.94 | |
| Q1  2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 2,424 | 0.01 | |
| ≡ | Samantha McLemore - Patient Capital Management | Add 1.92% | 4,609 | 0.03 | |
| ≡ | Polen Capital Management | Sell 100.00% | 33,913 | 0.20 | |
| ≡ | ValueAct Capital | Reduce 25.69% | 84,268 | 0.26 | |
| Q4  2023 | |||||
| ≡ | ValueAct Capital | Reduce 36.87% | 191,565 | 0.53 | |
| ≡ | Samantha McLemore - Patient Capital Management | Buy | 240,678 | 1.78 | |
| ≡ | Polen Capital Management | Reduce 99.34% | 5,092,701 | 30.03 | |
| Q3  2023 | |||||
| ≡ | Polen Capital Management | Add 0.57% | 29,153 | 0.01 | |
| ≡ | ValueAct Capital | Buy | 519,610 | 1.60 | |
| Q2  2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 1,425 | 0.01 | |
| ≡ | Polen Capital Management | Add 0.29% | 14,983 | 0.01 | |
| Q1  2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 1,425 | 0.01 | |
| ≡ | Polen Capital Management | Add 0.67% | 34,076 | 0.02 | |
| ≡ | Carl Icahn - Icahn Capital Management | Buy | 430,000 | 0.45 | |
| Q4  2022 | |||||
| ≡ | Polen Capital Management | Add 11.66% | 527,005 | 0.31 | |
| Q3  2022 | |||||
| ≡ | Polen Capital Management | Add 62.04% | 1,731,169 | 0.93 | |
| Q2  2022 | |||||
| ≡ | Polen Capital Management | Add 6.05% | 159,057 | 0.08 | |
| Q1  2022 | |||||
| ≡ | Polen Capital Management | Reduce 1.18% | 31,531 | 0.02 | |
| Q4  2021 | |||||
| ≡ | Thomas Gayner - Markel Group | Sell 100.00% | 4,000 | 0.02 | |
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 6,519 | 0.03 | |
| ≡ | Polen Capital Management | Add 4.99% | 126,623 | 0.08 | |
| ≡ | Viking Global Investors | Sell 100.00% | 155,319 | 0.18 | |
| Q3  2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 130.52% | 3,691 | 0.02 | |
| ≡ | Polen Capital Management | Add 2.23% | 55,303 | 0.04 | |
| ≡ | Viking Global Investors | Buy | 155,319 | 0.18 | |
| Q2  2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 86.42% | 1,311 | 0.00 | |
| ≡ | Polen Capital Management | Add 4.36% | 103,747 | 0.09 | |
| Q1  2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 975.89% | 1,376 | 0.01 | |
| ≡ | Polen Capital Management | Add 2.09% | 48,751 | 0.04 | |
| Q4  2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 141 | 0.00 | |
| ≡ | Polen Capital Management | Add 313.71% | 1,765,503 | 1.52 | |
| Q3  2020 | |||||
| ≡ | Polen Capital Management | Buy | 562,775 | 0.47 | |
| Q1  2020 | |||||
| ≡ | Thomas Gayner - Markel Group | Add 300.00% | 3,000 | 0.02 | |
| ≡ | Viking Global Investors | Sell 100.00% | 408,658 | 0.63 | |
| ≡ | Stephen Mandel - Lone Pine Capital | Sell 100.00% | 519,808 | 0.92 | |
| Q4  2019 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Buy | 519,808 | 0.92 | |
| ≡ | Viking Global Investors | Reduce 78.79% | 1,518,298 | 2.34 | |
| Q3  2019 | |||||
| ≡ | Viking Global Investors | Add 40.54% | 555,869 | 0.88 | |
| Q2  2019 | |||||
| ≡ | Viking Global Investors | Add 15.97% | 188,763 | 0.31 | |
| Q4  2017 | |||||
| ≡ | Thomas Gayner - Markel Group | Buy | 1,000 | 0.00 | |
| Q2  2016 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Sell 100.00% | 1,675,158 | 1.38 | |
| Q1  2016 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Reduce 53.59% | 1,934,677 | 1.59 | |
| Q4  2015 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Add 0.00% | 100 | 0.00 | |
| Q3  2015 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Reduce 36.43% | 2,068,802 | 1.62 | |
| Q2  2015 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Add 96.48% | 2,788,434 | 2.71 | |
| Q1  2015 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Buy | 2,890,103 | 2.29 | |
| Q3  2008 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Sell 100.00% | 4,323,686 | 2.76 | |
| Q2  2008 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Reduce 9.97% | 478,792 | 0.31 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.